The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
APTOSE BIOSCIENCES INC | COM NEW | 03835T200 | 20,580 | 3,430,000 | SH | SOLE | 3,430,000 | 0 | 0 | ||
AURYN RESOURCES RESTRICTED | STOCK | 05208W124 | 2,252 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
AXOVANT SCIENCES LTD | COM | G0750W203 | 4,043 | 875,000 | SH | SOLE | 875,000 | 0 | 0 | ||
BEYOND MEAT INC | COM | 08862E109 | 5,812 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | ||
CARDIFF ONCOLOGY INC | COM | 14147L108 | 12,913 | 910,000 | SH | SOLE | 910,000 | 0 | 0 | ||
CHIMERIX INC | COM | 16934W106 | 122 | 49,085 | SH | SOLE | 49,085 | 0 | 0 | ||
CUE BIOPHARMA INC | COM | 22978P106 | 21,634 | 1,437,445 | SH | SOLE | 1,437,445 | 0 | 0 | ||
DATADOG INC | CL A COM | 23804L103 | 4,086 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
DIAMEDICA THERAPEUTICS INC | COM NEW | 25253X207 | 3,095 | 730,000 | SH | SOLE | 730,000 | 0 | 0 | ||
MAXAR TECHNOLOGIES INC | COM | 57778K105 | 49,183 | 1,972,061 | SH | SOLE | 1,972,061 | 0 | 0 | ||
REATA PHARMACEUTICALS INC | CL A | 75615P103 | 29,226 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
REPLIMUNE GROUP INC | COM | 76029N106 | 11,798 | 512,500 | SH | SOLE | 512,500 | 0 | 0 | ||
ROKU INC | COM CL A | 77543R102 | 3,776 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
TFF PHARMACEUTICALS INC | COM | 87241J104 | 19,556 | 1,058,823 | SH | SOLE | 1,058,823 | 0 | 0 | ||
VILLAGE FARMS INTL INC | COM | 92707Y108 | 4,321 | 943,396 | SH | SOLE | 943,396 | 0 | 0 | ||
VIRGIN GALACTIC HOLDINGS INC | COM | 92766K106 | 4,808 | 250,000 | SH | SOLE | 250,000 | 0 | 0 |